SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PharmAla Signs Corealis Pharma Agreement for ALA-002 Manufacturing

PharmAla signed an agreement with Corealis Pharma and initiated research and development for GMP manufacturing of its patented ALA-002 drug product.

MDXXF

Related stories